Interventions to improve antibiotic prescribing practices for hospital inpatients

Peter Davey, Charis A Marwick, Claire L Scott, Esmita Charani, Kirsty McNeil, Erwin Brown, Ian M Gould, Craig R Ramsay, Susan Michie, Peter Davey, Charis A Marwick, Claire L Scott, Esmita Charani, Kirsty McNeil, Erwin Brown, Ian M Gould, Craig R Ramsay, Susan Michie

Abstract

Background: Antibiotic resistance is a major public health problem. Infections caused by multidrug-resistant bacteria are associated with prolonged hospital stay and death compared with infections caused by susceptible bacteria. Appropriate antibiotic use in hospitals should ensure effective treatment of patients with infection and reduce unnecessary prescriptions. We updated this systematic review to evaluate the impact of interventions to improve antibiotic prescribing to hospital inpatients.

Objectives: To estimate the effectiveness and safety of interventions to improve antibiotic prescribing to hospital inpatients and to investigate the effect of two intervention functions: restriction and enablement.

Search methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (the Cochrane Library), MEDLINE, and Embase. We searched for additional studies using the bibliographies of included articles and personal files. The last search from which records were evaluated and any studies identified incorporated into the review was January 2015.

Selection criteria: We included randomised controlled trials (RCTs) and non-randomised studies (NRS). We included three non-randomised study designs to measure behavioural and clinical outcomes and analyse variation in the effects: non- randomised trials (NRT), controlled before-after (CBA) studies and interrupted time series (ITS) studies. For this update we also included three additional NRS designs (case control, cohort, and qualitative studies) to identify unintended consequences. Interventions included any professional or structural interventions as defined by the Cochrane Effective Practice and Organisation of Care Group. We defined restriction as 'using rules to reduce the opportunity to engage in the target behaviour (or increase the target behaviour by reducing the opportunity to engage in competing behaviours)'. We defined enablement as 'increasing means/reducing barriers to increase capability or opportunity'. The main comparison was between intervention and no intervention.

Data collection and analysis: Two review authors extracted data and assessed study risk of bias. We performed meta-analysis and meta-regression of RCTs and meta-regression of ITS studies. We classified behaviour change functions for all interventions in the review, including those studies in the previously published versions. We analysed dichotomous data with a risk difference (RD). We assessed certainty of evidence with GRADE criteria.

Main results: This review includes 221 studies (58 RCTs, and 163 NRS). Most studies were from North America (96) or Europe (87). The remaining studies were from Asia (19), South America (8), Australia (8), and the East Asia (3). Although 62% of RCTs were at a high risk of bias, the results for the main review outcomes were similar when we restricted the analysis to studies at low risk of bias.More hospital inpatients were treated according to antibiotic prescribing policy with the intervention compared with no intervention based on 29 RCTs of predominantly enablement interventions (RD 15%, 95% confidence interval (CI) 14% to 16%; 23,394 participants; high-certainty evidence). This represents an increase from 43% to 58% .There were high levels of heterogeneity of effect size but the direction consistently favoured intervention.The duration of antibiotic treatment decreased by 1.95 days (95% CI 2.22 to 1.67; 14 RCTs; 3318 participants; high-certainty evidence) from 11.0 days. Information from non-randomised studies showed interventions to be associated with improvement in prescribing according to antibiotic policy in routine clinical practice, with 70% of interventions being hospital-wide compared with 31% for RCTs. The risk of death was similar between intervention and control groups (11% in both arms), indicating that antibiotic use can likely be reduced without adversely affecting mortality (RD 0%, 95% CI -1% to 0%; 28 RCTs; 15,827 participants; moderate-certainty evidence). Antibiotic stewardship interventions probably reduce length of stay by 1.12 days (95% CI 0.7 to 1.54 days; 15 RCTs; 3834 participants; moderate-certainty evidence). One RCT and six NRS raised concerns that restrictive interventions may lead to delay in treatment and negative professional culture because of breakdown in communication and trust between infection specialists and clinical teams (low-certainty evidence).Both enablement and restriction were independently associated with increased compliance with antibiotic policies, and enablement enhanced the effect of restrictive interventions (high-certainty evidence). Enabling interventions that included feedback were probably more effective than those that did not (moderate-certainty evidence).There was very low-certainty evidence about the effect of the interventions on reducing Clostridium difficile infections (median -48.6%, interquartile range -80.7% to -19.2%; 7 studies). This was also the case for resistant gram-negative bacteria (median -12.9%, interquartile range -35.3% to 25.2%; 11 studies) and resistant gram-positive bacteria (median -19.3%, interquartile range -50.1% to +23.1%; 9 studies). There was too much variance in microbial outcomes to reliably assess the effect of change in antibiotic use. Heterogeneity of intervention effect on prescribing outcomesWe analysed effect modifiers in 29 RCTs and 91 ITS studies. Enablement and restriction were independently associated with a larger effect size (high-certainty evidence). Feedback was included in 4 (17%) of 23 RCTs and 20 (47%) of 43 ITS studies of enabling interventions and was associated with greater intervention effect. Enablement was included in 13 (45%) of 29 ITS studies with restrictive interventions and enhanced intervention effect.

Authors' conclusions: We found high-certainty evidence that interventions are effective in increasing compliance with antibiotic policy and reducing duration of antibiotic treatment. Lower use of antibiotics probably does not increase mortality and likely reduces length of stay. Additional trials comparing antibiotic stewardship with no intervention are unlikely to change our conclusions. Enablement consistently increased the effect of interventions, including those with a restrictive component. Although feedback further increased intervention effect, it was used in only a minority of enabling interventions. Interventions were successful in safely reducing unnecessary antibiotic use in hospitals, despite the fact that the majority did not use the most effective behaviour change techniques. Consequently, effective dissemination of our findings could have considerable health service and policy impact. Future research should instead focus on targeting treatment and assessing other measures of patient safety, assess different stewardship interventions, and explore the barriers and facilitators to implementation. More research is required on unintended consequences of restrictive interventions.

Conflict of interest statement

Peter Davey is an author of four of the included studies. Charis Marwick is an author of two of the included studies. Ian Gould is an author of one of the included studies. Craig Ramsay is an author of one of the included studies. Other review authors completed data extractions for these studies. The institutions of the following authors received funding from the Chief Scientist Office that helped to support the conduct of this review: Peter Davey, Charis Marwick, Esmita Charani.

Peter Davey, none other than as indicated above. Charis Marwick, none other than as indicated above. Claire Scott, none other than as indicated above. Esmita Charani, none other than as indicated above. Kirsty McNeil, none other than as indicated above. Susan Michie, none other than as indicated above. Erwin Brown, none other than as indicated above. Ian Gould, none other than as indicated above. Craig Ramsay, none other than as indicated above.

Figures

1
1
Figure 1 Study flow diagram.
2
2
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. Blank sections in this graph are due to use of different ROB criteria for CBA, NRT and RCT versus ITS studies
3
3
Forest plot of comparison: 1 Prescribing: RCTs of all interventions to reduce unnecessary prescribing, outcome: 1.1 Dichotomous outcomes, increase in desired practice.
4
4
Forest plot of comparison: 1 Effectiveness: Prescribing outcomes from RCTs of interventions to reduce unnecessary antibiotic use, outcome: 1.4 Continuous outcomes, duration of all antibiotic treatment (days).
5
5
Forest plot of comparison: 2 Adverse effects: Clinical outcomes from RCTs of interventions to reduce unnecessary antibiotic use, outcome: 2.1 Mortality, all RCTs.
6
6
Forest plot of comparison: 2 Adverse effects: Clinical outcomes from RCTs of interventions to reduce unnecessary antibiotic use, outcome: 2.4 Length of stay, all RCTs.
7
7
Meta‐regression by effect modifier for 29 RCTs. A positive value for Beta indicates enhanced intervention effect. One RCT had both enabling and restrictive components in the intervention (Strom 2010).
8
8
Forest plot of comparison 5: RCTs of enablement with and without feedback, outcome: 5.1 Enablement plus feedback.
9
9
Forest plot of comparison 5: RCTs of enablement with and without feedback, outcome: 5.2 Enablement without feedback.
10
10
Meta‐regression by effect modifiers of intervention for 91 ITS studies. Outcome is effect on prescribing six months' postintervention. There are 16 studies with both enabling and restricting intervention components (Figure 11).
11
11
Meta‐regression of prescribing outcome by effect modifiers for 29 ITS studies of interventions that included restriction.
12
12
Meta‐regression by effect modifier for 43 ITS studies of interventions that included enablement but not restriction. Outcome is effect on prescribing six months' postintervention. Note that four studies with feedback were not included in this analysis because they also included restriction.
13
13
Meta‐regression by effect modifiers for 34 microbial outcomes 12 months' postintervention from 26 ITS studies. The bars show the results for unadjusted versus adjusted analyses, the comparison for unplanned interventions is with planned interventions in both the unadjusted and adjusted analysis. CDI: Clostridium difficile infection
 GPC: infection with antibiotic‐resistant gram‐positive cocci
 GNB: infection with antibiotic‐resistant gram‐negative bacteria Other infection control: 'Yes' means there were changes to infection control processes during the study period.
14
14
Meta‐regression by effect modifiers for 20 microbial outcomes 12 months' postintervention from 14 ITS studies of planned interventions that provided details about other infection control changes or interventions. CDI: Clostridium difficile infection
 GPC: infection with antibiotic‐resistant gram‐positive cocci
 GNB: infection with antibiotic‐resistant gram‐negative bacteria Other infection control: 'Yes' means there were changes to infection control processes during the study period.
1.1. Analysis
1.1. Analysis
Comparison 1 Effectiveness: Prescribing outcomes from RCTs of interventions to reduce unnecessary antibiotic use, Outcome 1 Dichotomous outcomes, increase in desired practice.
1.2. Analysis
1.2. Analysis
Comparison 1 Effectiveness: Prescribing outcomes from RCTs of interventions to reduce unnecessary antibiotic use, Outcome 2 Dichotomous outcomes, all RCTs with results of cluster RCTs adjusted by inflation factor.
1.3. Analysis
1.3. Analysis
Comparison 1 Effectiveness: Prescribing outcomes from RCTs of interventions to reduce unnecessary antibiotic use, Outcome 3 Dichotomous outcomes, low or medium 'Risk of bias' studies only.
1.4. Analysis
1.4. Analysis
Comparison 1 Effectiveness: Prescribing outcomes from RCTs of interventions to reduce unnecessary antibiotic use, Outcome 4 Continuous outcomes, duration of all antibiotic treatment (days).
1.5. Analysis
1.5. Analysis
Comparison 1 Effectiveness: Prescribing outcomes from RCTs of interventions to reduce unnecessary antibiotic use, Outcome 5 Continuous outcomes, duration of all antibiotic treatment with results of cluster RCTs adjusted by inflation factor.
1.6. Analysis
1.6. Analysis
Comparison 1 Effectiveness: Prescribing outcomes from RCTs of interventions to reduce unnecessary antibiotic use, Outcome 6 Continuous outcomes, low or medium 'Risk of bias' studies only.
1.7. Analysis
1.7. Analysis
Comparison 1 Effectiveness: Prescribing outcomes from RCTs of interventions to reduce unnecessary antibiotic use, Outcome 7 Continuous outcome, consumption of targeted antibiotic only, standardised mean reduction (original outcome cost, days or DDD).
2.1. Analysis
2.1. Analysis
Comparison 2 Adverse effects: Clinical outcomes from RCTs of interventions to reduce unnecessary antibiotic use, Outcome 1 Mortality, all RCTs.
2.2. Analysis
2.2. Analysis
Comparison 2 Adverse effects: Clinical outcomes from RCTs of interventions to reduce unnecessary antibiotic use, Outcome 2 Mortality, all RCTs with results of cluster RCTs adjusted by inflation factor.
2.3. Analysis
2.3. Analysis
Comparison 2 Adverse effects: Clinical outcomes from RCTs of interventions to reduce unnecessary antibiotic use, Outcome 3 Mortality, low or medium 'Risk of bias' RCTs.
2.4. Analysis
2.4. Analysis
Comparison 2 Adverse effects: Clinical outcomes from RCTs of interventions to reduce unnecessary antibiotic use, Outcome 4 Length of stay, all RCTs.
2.5. Analysis
2.5. Analysis
Comparison 2 Adverse effects: Clinical outcomes from RCTs of interventions to reduce unnecessary antibiotic use, Outcome 5 Length of stay, all RCTs with results of cluster RCTs adjusted by inflation factor.
2.6. Analysis
2.6. Analysis
Comparison 2 Adverse effects: Clinical outcomes from RCTs of interventions to reduce unnecessary antibiotic use, Outcome 6 Length of stay, low or medium 'Risk of bias' RCTs only.
3.1. Analysis
3.1. Analysis
Comparison 3 Adverse effects: Clinical outcomes of interventions targeting antibiotic choice, Outcome 1 Mortality for trial patients.
3.2. Analysis
3.2. Analysis
Comparison 3 Adverse effects: Clinical outcomes of interventions targeting antibiotic choice, Outcome 2 Length of stay for trial patients.
4.1. Analysis
4.1. Analysis
Comparison 4 Adverse effects: Clinical outcomes of interventions targeting antibiotic exposure, Outcome 1 Mortality for trial patients.
4.2. Analysis
4.2. Analysis
Comparison 4 Adverse effects: Clinical outcomes of interventions targeting antibiotic exposure, Outcome 2 Length of stay for trial patients.
5.1. Analysis
5.1. Analysis
Comparison 5 Modifiers of intended effect: Comparison of enabling interventions with and without feedback, Outcome 1 Enablement with feedback.
5.2. Analysis
5.2. Analysis
Comparison 5 Modifiers of intended effect: Comparison of enabling interventions with and without feedback, Outcome 2 Enablement without feedback.

Source: PubMed

3
S'abonner